PHARMAC - Latest News [Page 1]

Pharmac welcomes appointments to clinical committee

Friday, 17 July 2015, 10:31 am | PHARMAC

Pharmac welcomes appointments to clinical committee Pharmac medical director Dr John Wyeth is welcoming the appointment of a new Chair and two new members to the Pharmacology and Therapeutics Advisory Committee (PTAC). PTAC is a statutory committee ... More >>

New leadership, new members for PHARMAC consumer committee

Thursday, 9 July 2015, 10:17 am | PHARMAC

New leadership, new members for PHARMAC consumer committee Wellington smoking cessation advocate Shane Bradbrook has been appointed chair of PHARMAC’s Consumer Advisory Committee. Shane Bradbrook, a member of the Committee since 2010, will succeed Kate ... More >>

Moves to protect availability of haemophilia treatments

Monday, 6 July 2015, 3:45 pm | PHARMAC

In changes to take effect from 1 September, PHARMAC is moving to have a preferred brand of recombinant Factor VIII, while also maintaining full funding for the other three currently-funded haemophilia products. More >>

PHARMAC Moving to Next Stage of Medical Devices Activity

Tuesday, 14 April 2015, 11:17 am | PHARMAC

PHARMAC is now consulting on moving to the next stage in its hospital medical devices work – market share procurement. This next stage of activity would see PHARMAC offering suppliers an assured portion of the market in return for competitive pricing ... More >>

PHARMAC tender savings top $600 million

Tuesday, 17 March 2015, 11:41 am | PHARMAC

Estimated savings achieved through PHARMAC’s tender of off-patent medicines have now topped $600 million. PHARMAC has run a tender for off-patent medicines since 1997. The tender promotes competition among pharmaceutical companies to bid for sole ... More >>

PHARMAC in negotiations over rare disorders medicines

Friday, 27 February 2015, 9:03 am | PHARMAC

PHARMAC is in active negotiations with several suppliers as a result of its competitive process for rare disorders medicines. On the eve of World Rare Diseases Day, PHARMAC has announced that 28 proposals from eight suppliers emerged from its request for ... More >>

PHARMAC secures significant savings for DHBs

Thursday, 4 December 2014, 2:57 pm | PHARMAC

A new agreement for a high cost biologic drug will yield considerable savings for DHBs over the next five years, says PHARMAC. Infliximab is a monoclonal antibody, one of the so-called `targeted drugs’ used to treat auto-immune conditions like ... More >>

PHARMAC expands into new medical device category

Monday, 3 November 2014, 2:27 pm | PHARMAC

DHBs are expected to start making further savings in cardiac medical devices, after PHARMAC extended the range of products it already has under national contracts by beginning listing those used in cardiac procedures. More >>

PHARMAC approves largest single deal

Tuesday, 14 October 2014, 9:56 am | PHARMAC

Nearly 12,000 New Zealanders are set to benefit from major agreements that have been approved by PHARMAC. Agreements with two companies, Novartis and Biogen Idec, have been approved which will see 10 new medicines funded, and either reduced prices or ... More >>

Tender for generic medicines contributes $38 million savings

Monday, 18 August 2014, 3:25 pm | PHARMAC

New Zealanders’ use of generic medicines is likely to grow further following the just-completed 2013/14 PHARMAC tender. The tender reached record levels this year, receiving nearly 3500 offers to supply pharmaceuticals from 54 companies. More >>

Savings for DHBs in medical equipment agreement

Friday, 15 August 2014, 10:54 am | PHARMAC

DHBs will save another $650,000 a year from lower priced wound care and surgery equipment through a new national PHARMAC agreement with a major medical device supplier. More >>

PHARMAC welcomes updated Medicines NZ Code of Practice

Wednesday, 13 August 2014, 9:57 am | PHARMAC

PHARMAC is welcoming the publication of an updated Medicines NZ Code of Practice (COP). The Code, now in its 16th edition, has been updated following feedback from stakeholders in the pharmaceutical sector, including PHARMAC. Chief executive Steffan ... More >>

PHARMAC looks to Pasifika community for advisory committee

Wednesday, 16 July 2014, 3:11 pm | PHARMAC

PHARMAC has appointed three new members to its Consumer Advisory Committee (CAC), all with strong links to the Pasifika community. More >>

Two new appointments to PHARMAC advisory committee

Wednesday, 18 June 2014, 10:04 am | PHARMAC

PHARMAC is welcoming the appointment of two new members to the Pharmacology and Therapeutics Advisory Committee (PTAC). PTAC provides PHARMAC with expert clinical advice on pharmaceutical funding applications being considered by PHARMAC, and other ... More >>

New treatment funded for severe gout

Wednesday, 21 May 2014, 2:24 pm | PHARMAC

New treatment funded for severe gout Patients with severe gout will soon have a new treatment option as PHARMAC will be funding febuxostat (Adenuric) from 1 June 2014. Gout is a painful form of arthritis, and is associated with high levels of uric acid ... More >>

Promoting competition key for high cost medicines

Tuesday, 8 April 2014, 11:12 am | PHARMAC

PHARMAC has announced its intention to test out a contestable fund for high cost medicines for rare disorders, which could be seeking proposals from pharmaceutical companies by the end of 2014. More >>

PHARMAC seeking public views on new decision criteria

Tuesday, 25 February 2014, 10:51 am | PHARMAC

PHARMAC is asking for people’s views on a proposed new framework for making pharmaceutical funding decisions. More >>

PHARMAC tender reveals vibrant market for pharmaceuticals

Wednesday, 12 February 2014, 10:46 am | PHARMAC

The number of companies bidding to be suppliers through the PHARMAC tender has grown to its largest size ever. PHARMAC runs a tender each year, asking pharmaceutical suppliers to provide pricing proposals for off-patent medicines listed on the Pharmaceutical ... More >>

Lung cancer treatment takes another forward step

Thursday, 9 January 2014, 8:50 am | PHARMAC

Improvements in lung cancer treatment are set to continue with a PHARMAC decision to extend funding for erlotinib (Tarceva) from 1 January 2014. More >>

Rotavirus, varicella vaccines added to national schedule

Tuesday, 17 December 2013, 11:44 am | PHARMAC

Rotavirus, varicella vaccines added to national immunisation schedule The addition of rotavirus vaccine to the list of funded vaccines will have a long-lasting positive effect on children’s health, says PHARMAC Medical Director Dr John Wyeth. PHARMAC ... More >>



InfoPages Links



Search Scoop  
Powered by Vodafone
NZ independent news